UK markets closed

Eagle Pharmaceuticals, Inc. (1E6.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
4.5200-0.0800 (-1.74%)
At close: 08:32AM CET
Currency in EUR
Earnings estimateCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
No. of analysts3333
Avg. Estimate0.8313.025.65
Low estimate0.770.782.855.2
High estimate0.891.283.235.89
Year ago EPS1.170.963.543.02
Revenue estimateCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
No. of analysts3333
Avg. Estimate46.4M53.1M188.85M283.81M
Low estimate44.6M46.9M180.86M254.4M
High estimate48.8M59.5M194.7M306.3M
Year ago sales47.02M49.92M187.8M188.85M
Sales growth (year/est)-1.30%6.40%0.60%50.30%
Earnings history30/09/202031/12/202031/03/202130/06/2021
Est. EPS0.29-0.170.650.8
Actual EPS1.170.960.240.93
Difference0.881.13-0.410.13
Surprise %303.40%664.70%-63.10%16.20%
EPS trendCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
Current estimate0.8313.025.65
7 days ago0.831.033.045.54
30 days ago0.841.13.124.69
60 days ago0.951.163.154.16
90 days ago0.951.163.154.16
EPS revisionsCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
Up last 7 days1111
Up last 30 days2112
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimates1E6.FIndustrySector(s)S&P 500
Current qtr.-29.10%N/AN/AN/A
Next qtr.4.20%N/AN/AN/A
Current year-14.70%N/AN/AN/A
Next year87.10%N/AN/AN/A
Next 5 years (per annum)2.70%N/AN/AN/A
Past 5 years (per annum)16.79%N/AN/AN/A